Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Pleural Effusion, Malignant

fluorodeoxyglucose f18 has been researched along with Pleural Effusion, Malignant in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.35)18.2507
2000's6 (26.09)29.6817
2010's12 (52.17)24.3611
2020's4 (17.39)2.80

Authors

AuthorsStudies
Bhatnagar, R; Bodtger, U; Fjaellegaard, K; Frost Clementsen, P; Gerke, O; Koefod Petersen, J; Laursen, CB; Malene Fischer, B; Porcel, JM; Reuter, S1
Driessen, CML; Nagarajah, J; Uijen, MJM; van Herpen, CML; Weijers, JAM1
Alemán, C; Montoro, B; Persiva, O; Sánchez, L; Sansano, I; Simó, M; Vázquez, A1
Malik, D1
Kirchner, J; Riedl, CC; Ulaner, GA1
Grosu, HB; Kalhor, N; Miller, R; Mudambi, L; Vial, MR1
Fukunaga, H; Mutoh, T; Nakagawa, M; Shimomura, H; Taki, Y; Tatewaki, Y; Terao, C; Totsune, T; Yamamoto, S1
Jiang, T; Li, W; Shi, HZ; Tong, ZH; Wang, W; Wang, XJ; Wang, Z; Wu, XZ; Xu, LL; Yang, MF; Zhang, YH; Zhang, YY1
Choi, JY; Hong, JY; Jung, CW; Kim, HJ; Kim, SJ; Kim, WS; Ko, YH1
Anil, G; Singh, P1
Abe, K; Nakajima, R; Sakai, S1
Abid, Q; Srinivasan, L; Taylor, M1
Lu, P; Ma, J; Sun, Y; Yu, H1
Bury, T; Corhay, JL; Duysinx, B; Hustinx, R; Larock, MP; Louis, R; Nguyen, D1
Gerbaudo, VH; Gill, RR; Hatabu, H; Sugarbaker, DJ1
Alkhawaldeh, K; Biersack, HJ; Ezziddin, S; Henke, A1
Dong, S; Liao, R; Nie, Q; Wang, S; Wu, Y; Yang, X; Zhong, W; Zhou, Q1
Avril, N; Baccarini, M; Luong, P; Phillips, MM; Sheaff, MT; Stephen, E; Szlosarek, PW; Szyszko, T1
Atkins, M; Graeber, GM; Gregory, JL; Gupta, NC; Mullet, D; Rogers, JS; Waheed, U1
Aquino, SL; Fischman, AJ; Kwek, BH1
Albelda, SM; Benedict, W; Brown, JL; Carroll, RG; Corbley, MJ; Gillespie, CT; Haas, A; Heitjan, DF; Ho, M; Hodinka, R; June, CH; Kaiser, LR; Kanther, M; Kapoor, V; Litzky, LA; Lord, EM; Machuzak, M; Parr, M; Pastan, I; Recio, A; Sterman, DH; Sun, J; Vachani, A; Vonderheide, RH; Zhang, XQ1
Buchmann, I; Buck, A; Elsner, K; Gfrörer, W; Guhlmann, CA; Kotzerke, J; Reske, SN; Schirrmeister, H1
Coleman, RE; Erasmus, JJ; Goodman, PC; McAdams, HP; Patz, EF; Rossi, SE1

Reviews

3 review(s) available for fluorodeoxyglucose f18 and Pleural Effusion, Malignant

ArticleYear
Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.
    Lung cancer (Amsterdam, Netherlands), 2021, Volume: 162

    Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity

2021
Yttrium-90 radioembolization of liver tumors: what do the images tell us?
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2014, Jan-03, Volume: 13, Issue:4

    Topics: Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Liver Abscess; Liver Neoplasms; Multimodal Imaging; Pleural Effusion, Malignant; Positron-Emission Tomography; Tomography, X-Ray Computed; Yttrium Radioisotopes

2014
Current trends in radiologic management of malignant pleural mesothelioma.
    Seminars in thoracic and cardiovascular surgery, 2009,Summer, Volume: 21, Issue:2

    Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mesothelioma; Neoplasm Invasiveness; Neoplasm Staging; Palliative Care; Pleural Effusion, Malignant; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgical Procedures; Tomography, X-Ray Computed; Treatment Outcome

2009

Trials

2 trial(s) available for fluorodeoxyglucose f18 and Pleural Effusion, Malignant

ArticleYear
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Aug-01, Volume: 13, Issue:15 Pt 1

    Topics: Adenoviridae; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Female; Fluorodeoxyglucose F18; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Interferon-beta; Killer Cells, Natural; Male; Mesothelioma; Middle Aged; Pleural Effusion, Malignant; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; T-Lymphocytes, Cytotoxic

2007
FDG PET of pleural effusions in patients with non-small cell lung cancer.
    AJR. American journal of roentgenology, 2000, Volume: 175, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Radiopharmaceuticals; Tomography, Emission-Computed

2000

Other Studies

18 other study(ies) available for fluorodeoxyglucose f18 and Pleural Effusion, Malignant

ArticleYear
68Ga-Prostate-Specific Membrane Antigen-Avid Malignant Pleural Effusion in a Patient With Metastatic Adenoid Cystic Carcinoma and Concordance With 18F-FDG PET/CT.
    Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2

    Topics: Carcinoma, Adenoid Cystic; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Prostate

2022
A PET-CT score for discriminating malignant from benign pleural effusions.
    Medicina clinica, 2023, Nov-24, Volume: 161, Issue:10

    Topics: Cardiomegaly; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pleural Effusion; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity

2023
Comment on: "the FDG PET/CT score" for the diagnosis of malignant pleural effusion.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:1

    Topics: Fluorodeoxyglucose F18; Humans; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals

2020
Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:12

    Topics: Aged; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Patient Positioning; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography

2019
Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.
    American journal of respiratory and critical care medicine, 2017, Aug-15, Volume: 196, Issue:4

    Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Pleural Effusion, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracoscopy

2017
A Case of Low-Grade Primary Cardiac Lymphoma with Pericardial Effusion Diagnosed by Combined 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) Imaging and Effusion Cytology.
    The American journal of case reports, 2018, Mar-14, Volume: 19

    Topics: Aged; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging

2018
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung; Lung Neoplasms; Male; Middle Aged; Observer Variation; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Young Adult

2019
Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
    Acta haematologica, 2014, Volume: 131, Issue:1

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Prednisone; Republic of Korea; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2014
Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.
    Medicine, 2015, Volume: 94, Issue:29

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Vertebrae; Tomography, X-Ray Computed

2015
Primary pulmonary monophasic synovial sarcoma: Evading diagnosis.
    Asian cardiovascular & thoracic annals, 2016, Volume: 24, Issue:2

    Topics: Aged; Biomarkers, Tumor; Fluorodeoxyglucose F18; Frozen Sections; Humans; Immunohistochemistry; Lung Neoplasms; Male; Molecular Diagnostic Techniques; Multimodal Imaging; Pleural Effusion, Malignant; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma, Synovial; Tomography, X-Ray Computed; Treatment Outcome

2016
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2016
Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion.
    Nuclear medicine communications, 2008, Volume: 29, Issue:11

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies

2008
Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:6

    Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed

2011
[Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2012, Volume: 15, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pleural Effusion, Malignant; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed

2012
Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Argininosuccinate Synthase; Asbestos; Cisplatin; Clinical Trials as Topic; DNA Methylation; Fatal Outcome; Fluorodeoxyglucose F18; Glutamates; Guanine; Humans; Hydrolases; Male; Mesothelioma; Middle Aged; Mutation; Occupational Exposure; Pemetrexed; Pleural Effusion, Malignant; Pleural Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Promoter Regions, Genetic; Radiopharmaceuticals

2013
Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
    Chest, 2002, Volume: 122, Issue:6

    Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed

2002
Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
    Chest, 2004, Volume: 125, Issue:6

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Pleurodesis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Talc; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome

2004
[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
    Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:8

    Topics: Adult; Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Radiopharmaceuticals; Tomography, Emission-Computed

1999